Related Experiment Video
Updated: Mar 23, 2026
09:19
Community-based Adapted Tango Dancing for Individuals with Parkinson's Disease and Older Adults
Published on: December 9, 2014
26.4K
[Update on Current Care Guideline: Parkinson's disease]
Duodecim; Laaketieteellinen Aikakauskirja
|April 6, 2016
Summary
Parkinson's disease treatment varies by age, starting with dopamine agonists or MAO-B inhibitors for younger patients. Advanced therapies and rehabilitation offer further management options for motor symptoms and complications.
Area of Science:
- Neurology
- Movement Disorders
Context:
- Parkinson's disease (PD) management requires tailored therapeutic strategies.
- Age and symptom severity influence initial and advanced treatment choices.
Purpose:
- To outline current therapeutic approaches for Parkinson's disease.
- To detail pharmacological and non-pharmacological interventions for motor complications.
Summary:
- Initial PD treatment for patients under 60-65 typically involves dopamine agonists or MAO-B inhibitors; levodopa is an option for older patients.
- Motor complications like on-off symptoms and dyskinesias may necessitate apomorphine injections/infusions, deep brain stimulation, or duodenal levodopa infusion.
- Rehabilitation is crucial for improving gait, balance, and speech, but requires consistent training for sustained benefits.
Impact:
- Provides a clinical overview for optimizing Parkinson's disease patient care.
- Highlights the importance of personalized treatment plans and multidisciplinary approaches in managing PD progression.
Related Concept Videos
01:24Parkinson's Disease: Treatment
1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
01:15Parkinson's Disease: Overview
2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
01:26Peripheral Artery Disease IV: Nursing Management
586
The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses,...
586
01:27Peripheral Artery Disease III: Interprofessional Care
543
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
543
01:37Neural Regulation
44.6K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.6K
01:22Alzheimer's Disease: Treatment
1.2K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.2K